New drug - Relistor
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Over the past decade, one of the government's key aims has been to ensure that public services are m... Read more
This time last year, Gordon Brown was still riding high in the opinion polls after a successful star... Read more
Practices have been affected by a raft of reforms and restructures that successive governments have ... Read more
When the quality framework was first conceived it was intended to improve outcomes for patients, par... Read more
Two years ago the GPC drew up a shortlist of its negotiating priorities. GP has used this as the bas... Read more
NHS spending was £35 billion when Labour came into power in 1997. By 2010/11 it is expected to reach... Read more
GP understands that health secretary Alan Johnson will not be attending week's LMCs conference. This... Read more
In the increasingly convoluted debate about Darzi reforms and 'polyclinics', GPs tend to be cast as ... Read more
In a spectacular U-turn NICE has backtracked on its recommendations for cardiovascular risk assessme... Read more
General practice is no longer a one-size fits all profession. It may have been the case at the found... Read more
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more
The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more